Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Bertrand

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Orthodontics & Craniofacial Research|March 10, 2025
Defective Incisor Development in Smad Interacting Protein 1 (Sip1) Null MiceMarie De Laet, Julie Bertrand, Elisa Vingerhoedt, et al.
European Journal of Clinical Pharmacology|May 15, 2009
Influence of pharmacogenetics on indinavir disposition and short-term response in HIV patients initiating HAARTJulie Bertrand, Jean-Marc Treluyer, Xavière Panhard, et al.
Psychopharmacology|August 3, 2016
A population approach to characterise amisulpride pharmacokinetics in older people and Alzheimer's diseaseSuzanne Reeves, Julie Bertrand, Fabrizia D'Antonio, et al.
The Journal of Infectious Diseases|August 31, 2013
Dependence of efavirenz- and rifampicin-isoniazid-based antituberculosis treatment drug-drug interaction on CYP2B6 and NAT2 genetic polymorphisms: ANRS 12154 study in CambodiaJulie Bertrand, Céline Verstuyft, Monidarin Chou, et al.
Statistics in Medicine|June 7, 2024
Model-based bioequivalence approach for sparse pharmacokinetic bioequivalence studies: Model selection or model averaging?Morgane Philipp, Adrien Tessier, Mark Donnelly, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 28, 2023
Evaluation of model-based bioequivalence approach for single sample pharmacokinetic studiesCoralie Tardivon, Florence Loingeville, Mark Donnelly, et al.
Biostatistics (Oxford, England)|July 23, 2020
Efficient model-based bioequivalence testingKathrin Möllenhoff, Florence Loingeville, Julie Bertrand, et al.
The British Journal of Psychiatry : the Journal of Mental Science|November 12, 2020
Towards safer risperidone prescribing in Alzheimer's diseaseSuzanne Reeves, Julie Bertrand, Hiroyuki Uchida, et al.
Antimicrobial Agents and Chemotherapy|August 11, 2010
Population pharmacokinetic-pharmacogenetic study of nevirapine in HIV-infected Cambodian patientsMonidarin Chou, Julie Bertrand, Olivier Segeral, et al.
Antimicrobial Agents and Chemotherapy|April 26, 2023
Pharmacokinetic Model of Tenofovir and Emtricitabine and Their Intracellular Metabolites in Patients in the ANRS 134-COPHAR 3 Trial Using Dose RecordsJulie Bertrand, Aurélie Barrail-Tran, Lucie Fayette, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Orthodontics & Craniofacial Research|March 10, 2025
Defective Incisor Development in Smad Interacting Protein 1 (Sip1) Null MiceMarie De Laet, Julie Bertrand, Elisa Vingerhoedt, et al.
European Journal of Clinical Pharmacology|May 15, 2009
Influence of pharmacogenetics on indinavir disposition and short-term response in HIV patients initiating HAARTJulie Bertrand, Jean-Marc Treluyer, Xavière Panhard, et al.
Psychopharmacology|August 3, 2016
A population approach to characterise amisulpride pharmacokinetics in older people and Alzheimer's diseaseSuzanne Reeves, Julie Bertrand, Fabrizia D'Antonio, et al.
The Journal of Infectious Diseases|August 31, 2013
Dependence of efavirenz- and rifampicin-isoniazid-based antituberculosis treatment drug-drug interaction on CYP2B6 and NAT2 genetic polymorphisms: ANRS 12154 study in CambodiaJulie Bertrand, Céline Verstuyft, Monidarin Chou, et al.
Statistics in Medicine|June 7, 2024
Model-based bioequivalence approach for sparse pharmacokinetic bioequivalence studies: Model selection or model averaging?Morgane Philipp, Adrien Tessier, Mark Donnelly, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 28, 2023
Evaluation of model-based bioequivalence approach for single sample pharmacokinetic studiesCoralie Tardivon, Florence Loingeville, Mark Donnelly, et al.
Biostatistics (Oxford, England)|July 23, 2020
Efficient model-based bioequivalence testingKathrin Möllenhoff, Florence Loingeville, Julie Bertrand, et al.
The British Journal of Psychiatry : the Journal of Mental Science|November 12, 2020
Towards safer risperidone prescribing in Alzheimer's diseaseSuzanne Reeves, Julie Bertrand, Hiroyuki Uchida, et al.
Antimicrobial Agents and Chemotherapy|August 11, 2010
Population pharmacokinetic-pharmacogenetic study of nevirapine in HIV-infected Cambodian patientsMonidarin Chou, Julie Bertrand, Olivier Segeral, et al.
Antimicrobial Agents and Chemotherapy|April 26, 2023
Pharmacokinetic Model of Tenofovir and Emtricitabine and Their Intracellular Metabolites in Patients in the ANRS 134-COPHAR 3 Trial Using Dose RecordsJulie Bertrand, Aurélie Barrail-Tran, Lucie Fayette, et al.
Pageof 6